Pharma Mar Stock Forward View - Accumulation Distribution

PHM Stock  EUR 77.50  1.75  2.21%   
Pharma Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Pharma Mar stock prices and determine the direction of Pharma Mar SA's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of Pharma Mar's historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, the value of RSI of Pharma Mar's share price is approaching 38 indicating that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Pharma Mar, making its price go up or down.

Momentum 38

 Sell Extended

 
Oversold
 
Overbought
The successful prediction of Pharma Mar's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Pharma Mar SA, which may create opportunities for some arbitrage if properly timed.
Using Pharma Mar hype-based prediction, you can estimate the value of Pharma Mar SA from the perspective of Pharma Mar response to recently generated media hype and the effects of current headlines on its competitors.

Pharma Mar after-hype prediction price

    
  EUR 79.25  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Historical Fundamental Analysis of Pharma Mar to cross-verify your projections.

Pharma Mar Additional Predictive Modules

Most predictive techniques to examine Pharma price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Pharma using various technical indicators. When you analyze Pharma charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Pharma Mar SA has current Accumulation Distribution of 0.027. The accumulation distribution (A/D) indicator shows the degree to which Pharma Mar is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Pharma Mar SA to determine if accumulation or reduction is taking place in the market. This value is adjusted by Pharma Mar trading volume to give more weight to distributions with higher volume over lower volume.
Check Pharma Mar VolatilityBacktest Pharma MarInformation Ratio  

Pharma Mar Trading Date Momentum

On February 20 2026 Pharma Mar SA was traded for  77.50  at the closing time. The maximum traded price for the trading interval was 79.65  and the lowest daily price was  77.50 . There was no trading activity during the period 0.0. Lack of trading volume on 20th of February 2026 did not cause price change. The trading delta at closing time to the closing price today is 1.81% .
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Pharma Mar to competition

Other Forecasting Options for Pharma Mar

For every potential investor in Pharma, whether a beginner or expert, Pharma Mar's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Pharma Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Pharma. Basic forecasting techniques help filter out the noise by identifying Pharma Mar's price trends.

Pharma Mar Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pharma Mar stock to make a market-neutral strategy. Peer analysis of Pharma Mar could also be used in its relative valuation, which is a method of valuing Pharma Mar by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Pharma Mar Market Strength Events

Market strength indicators help investors to evaluate how Pharma Mar stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pharma Mar shares will generate the highest return on investment. By undertsting and applying Pharma Mar stock market strength indicators, traders can identify Pharma Mar SA entry and exit signals to maximize returns.

Pharma Mar Risk Indicators

The analysis of Pharma Mar's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Pharma Mar's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting pharma stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for Pharma Mar

The number of cover stories for Pharma Mar depends on current market conditions and Pharma Mar's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Pharma Mar is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Pharma Mar's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Pharma Mar Short Properties

Pharma Mar's future price predictability will typically decrease when Pharma Mar's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Pharma Mar SA often depends not only on the future outlook of the potential Pharma Mar's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pharma Mar's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding18.1 M
Cash And Short Term Investments201.9 M

Other Information on Investing in Pharma Stock

Pharma Mar financial ratios help investors to determine whether Pharma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharma with respect to the benefits of owning Pharma Mar security.